Genotrop 100 IU - Genetic Pharmaceuticals

Human Growth Hormone therapy began with cadaver extraction—a method that limited access and exposed users to serious disease risk. In 1985, this approach was banned by the FDA after cases of Creutzfeldt-Jakob disease emerged. That same year marked the debut of somatrem, the first synthetic HGH approved for use, developed by Genentech. Although it differed slightly from natural HGH, it led directly to the release of somatropin, a fully bioidentical hormone that remains the gold standard in treating GH deficiency and metabolic conditions.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Genotrop 100 IU by Genetic Pharmaceuticals, consult with your doctor or healthcare professional.